| Issue Date | Title | Author(s) |
| 2019 | Correction of Experimental Retinal Ischemia by L-Isomer of Ethylmethylhydroxypyridine Malate | Peresypkina, A.; Pazhinsky, A.; Pokrovskii, M.; Beskhmelnitsyna, E.; Pobeda, A.; Korokin, M. |
| 2020 | Erythropoietin mimetic peptide (pHBSP) corrects endothelial dysfunction in a rat model of preeclampsia | Korokin, M.; Gureev, V.; Gudyrev, O.; Golubev, I.; Korokina, L.; Peresypkina, A.; Pokrovskaia, T. |
| 2017 | Pharmacokinetics of a new imidazoline receptor agonist in rat plasma after intragastric and intravenous administration | Kulikov, A.; Avtina, T.; Pokrovsky, M.; Korokin, M. |
| 2020 | Retinoprotective Effect of 2‐Ethyl‐3‐hydroxy‐6‐methylpyridine Nicotinate | Peresypkina, A.; Pokrovskii, M.; Korokin, M.; Soldatov, V.; Pokrovskii, V. |
| 2025 | Sex-dependent phenotypic and histomorphometric biomarkers in the APPswe/PS1de9/BLG mouse model of Alzheimer’s disease | Kuzubova, E.; Radchenko, A.; Pokrovskii, M.; Shcheblykina, O.; Nesterov, A.; Avtina, T.; Pokrovskii, V.; Korokin, M. |
| 2020 | Studies to Elucidate the Effects of Furostanol Glycosides from Dioscorea deltoidea Cell Culture in a Rat Model of Endothelial Dysfunction | Korokin, M.; Gudyrev, O.; Gureev, V.; Korokina, L.; Peresypkina, A.; Pokrovskaia, T.; Soldatov, V.; Pokrovskii, M. |
| 2017 | Study of pharmacological activity of Nigella damascena fixed oil in experiment | Efremova, M. P.; Ivasheva, A. V.; Korokin, M. |
| 2020 | Theoretical justification of a purposeful search of potential neurotropic drugs | Semenets, A.; Suleiman, M.; Pokrovskii, M.; Korokin, M.; Soldatov, V. |
| 2026 | Use of laser speckle contrast imaging for distribution of animals by severity of brain tissue damage in a neonatal hypoxia-ischemia model in mice | Pokrovskii, V.; Korokin, M.; Gudyrev, O.; Gureev, V.; Korokina, L.; Scheblykina, O.; Nesterov, A.; Maslinikova, M.; Chatsky, I.; Mukhamedov, D.; Pokrovskii, M. |
